Eureka Therapeutics Inc. 13D and 13G filings for Estrella Immunopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-27 7:27 pm Purchase |
2023-09-29 | 13D | Estrella Immunopharma, Inc. ESLA |
Eureka Therapeutics Inc. | 25,277,831 71.800% |
25,277,831 (New Position) |
Filing |